Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1998 Jun;62(6):1341–1352. doi: 10.1086/301870

Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria.

U B Rüfenacht 1, L Gouya 1, X Schneider-Yin 1, H Puy 1, B W Schäfer 1, R Aquaron 1, Y Nordmann 1, E I Minder 1, J C Deybach 1
PMCID: PMC1377149  PMID: 9585598

Abstract

Erythropoietic protoporphyria (EPP; MIM 177000) is an inherited disorder caused by partial deficiency of ferrochelatase (FECH), the last enzyme in the heme biosynthetic pathway. In EPP patients, the FECH deficiency causes accumulation of free protoporphyrin in the erythron, associated with a painful skin photosensitivity. In rare cases, the massive accumulation of protoporphyrin in hepatocytes may lead to a rapidly progressive liver failure. The mode of inheritance in EPP is complex and can be either autosomal dominant with low clinical penetrance, as it is in most cases, or autosomal recessive. To acquire an in-depth knowledge of the genetic basis of EPP, we conducted a systematic mutation analysis of the FECH gene, following a procedure that combines the exon-by-exon denaturing-gradient-gel-electrophoresis screening of the FECH genomic DNA and direct sequencing. Twenty different mutations, 15 of which are newly described here, have been characterized in 26 of 29 EPP patients of Swiss and French origin. All the EPP patients, including those with liver complications, were heterozygous for the mutations identified in the FECH gene. The deleterious effect of all missense mutations has been assessed by bacterial expression of the respective FECH cDNAs generated by site-directed mutagenesis. Mutations leading to a null allele were a common feature among three EPP pedigrees with liver complications. Our systematic molecular study has resulted in a significant enlargement of the mutation repertoire in the FECH gene and has shed new light on the hereditary behavior of EPP.

Full Text

The Full Text of this article is available as a PDF (1.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonkowsky H. L., Bloomer J. R., Ebert P. S., Mahoney M. J. Heme synthetase deficiency in human protoporphyria. Demonstration of the defect in liver and cultured skin fibroblasts. J Clin Invest. 1975 Nov;56(5):1139–1148. doi: 10.1172/JCI108189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boulechfar S., Lamoril J., Montagutelli X., Guenet J. L., Deybach J. C., Nordmann Y., Dailey H., Grandchamp B., de Verneuil H. Ferrochelatase structural mutant (Fechm1Pas) in the house mouse. Genomics. 1993 Jun;16(3):645–648. doi: 10.1006/geno.1993.1242. [DOI] [PubMed] [Google Scholar]
  3. Brenner D. A., Didier J. M., Frasier F., Christensen S. R., Evans G. A., Dailey H. A. A molecular defect in human protoporphyria. Am J Hum Genet. 1992 Jun;50(6):1203–1210. [PMC free article] [PubMed] [Google Scholar]
  4. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  5. Cox T. M. Erythropoietic protoporphyria. J Inherit Metab Dis. 1997 Jun;20(2):258–269. doi: 10.1023/a:1005317124985. [DOI] [PubMed] [Google Scholar]
  6. Dailey H. A., Sellers V. M., Dailey T. A. Mammalian ferrochelatase. Expression and characterization of normal and two human protoporphyric ferrochelatases. J Biol Chem. 1994 Jan 7;269(1):390–395. [PubMed] [Google Scholar]
  7. Deng W. P., Nickoloff J. A. Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal Biochem. 1992 Jan;200(1):81–88. doi: 10.1016/0003-2697(92)90280-k. [DOI] [PubMed] [Google Scholar]
  8. Gouya L., Deybach J. C., Lamoril J., Da Silva V., Beaumont C., Grandchamp B., Nordmann Y. Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferrochelatase allele. Am J Hum Genet. 1996 Feb;58(2):292–299. [PMC free article] [PubMed] [Google Scholar]
  9. Henriksson M., Timonen K., Mustajoki P., Pihlaja H., Tenhunen R., Peltonen L., Kauppinen R. Four novel mutations in the ferrochelatase gene among erythropoietic protoporphyria patients. J Invest Dermatol. 1996 Feb;106(2):346–350. doi: 10.1111/1523-1747.ep12343020. [DOI] [PubMed] [Google Scholar]
  10. Imoto S., Tanizawa Y., Sato Y., Kaku K., Oka Y. A novel mutation in the ferrochelatase gene associated with erythropoietic protoporphyria. Br J Haematol. 1996 Jul;94(1):191–197. doi: 10.1046/j.1365-2141.1996.d01-1771.x. [DOI] [PubMed] [Google Scholar]
  11. Lamoril J., Boulechfar S., de Verneuil H., Grandchamp B., Nordmann Y., Deybach J. C. Human erythropoietic protoporphyria: two point mutations in the ferrochelatase gene. Biochem Biophys Res Commun. 1991 Dec 16;181(2):594–599. doi: 10.1016/0006-291x(91)91231-z. [DOI] [PubMed] [Google Scholar]
  12. Lamoril J., Martasek P., Deybach J. C., Da Silva V., Grandchamp B., Nordmann Y. A molecular defect in coproporphyrinogen oxidase gene causing harderoporphyria, a variant form of hereditary coproporphyria. Hum Mol Genet. 1995 Feb;4(2):275–278. doi: 10.1093/hmg/4.2.275. [DOI] [PubMed] [Google Scholar]
  13. Lerman L. S., Silverstein K. Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis. Methods Enzymol. 1987;155:482–501. doi: 10.1016/0076-6879(87)55032-7. [DOI] [PubMed] [Google Scholar]
  14. Li F. M., Lim C. K., Peters T. J. An HPLC assay for rat liver ferrochelatase activity. Biomed Chromatogr. 1987;2(4):164–168. doi: 10.1002/bmc.1130020408. [DOI] [PubMed] [Google Scholar]
  15. Loparev V. N., Cartas M. A., Monken C. E., Velpandi A., Srinivasan A. An efficient and simple method of DNA extraction from whole blood and cell lines to identify infectious agents. J Virol Methods. 1991 Sep;34(1):105–112. doi: 10.1016/0166-0934(91)90126-k. [DOI] [PubMed] [Google Scholar]
  16. MAGNUS I. A., JARRETT A., PRANKERD T. A., RIMINGTON C. Erythropoietic protoporphyria. A new porphyria syndrome with solar urticaria due to protoporphyrinaemia. Lancet. 1961 Aug 26;2(7200):448–451. doi: 10.1016/s0140-6736(61)92427-8. [DOI] [PubMed] [Google Scholar]
  17. Magness S. T., Tugores A., Christensen S. R., Wagner-Mcpherson C., Evans G. A., Naylor E. W., Brenner D. A. Deletion of the ferrochelatase gene in a patient with protoporphyria. Hum Mol Genet. 1994 Sep;3(9):1695–1697. doi: 10.1093/hmg/3.9.1695. [DOI] [PubMed] [Google Scholar]
  18. Nakahashi Y., Miyazaki H., Kadota Y., Naitoh Y., Inoue K., Yamamoto M., Hayashi N., Taketani S. Human erythropoietic protoporphyria: identification of a mutation at the splice donor site of intron 7 causing exon 7 skipping of the ferrochelatase gene. Hum Mol Genet. 1993 Jul;2(7):1069–1070. doi: 10.1093/hmg/2.7.1069. [DOI] [PubMed] [Google Scholar]
  19. Nakahashi Y., Taketani S., Okuda M., Inoue K., Tokunaga R. Molecular cloning and sequence analysis of cDNA encoding human ferrochelatase. Biochem Biophys Res Commun. 1990 Dec 14;173(2):748–755. doi: 10.1016/s0006-291x(05)80099-3. [DOI] [PubMed] [Google Scholar]
  20. Norris P. G., Nunn A. V., Hawk J. L., Cox T. M. Genetic heterogeneity in erythropoietic protoporphyria: a study of the enzymatic defect in nine affected families. J Invest Dermatol. 1990 Sep;95(3):260–263. doi: 10.1111/1523-1747.ep12484876. [DOI] [PubMed] [Google Scholar]
  21. Puy H., Deybach J. C., Lamoril J., Robreau A. M., Da Silva V., Gouya L., Grandchamp B., Nordmann Y. Molecular epidemiology and diagnosis of PBG deaminase gene defects in acute intermittent porphyria. Am J Hum Genet. 1997 Jun;60(6):1373–1383. doi: 10.1086/515455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sarkany R. P., Alexander G. J., Cox T. M. Recessive inheritance of erythropoietic protoporphyria with liver failure. Lancet. 1994 Jun 4;343(8910):1394–1396. doi: 10.1016/s0140-6736(94)92525-9. [DOI] [PubMed] [Google Scholar]
  23. Sarkany R. P., Whitcombe D. M., Cox T. M. Molecular characterization of a ferrochelatase gene defect causing anomalous RNA splicing in erythropoietic protoporphyria. J Invest Dermatol. 1994 Apr;102(4):481–484. doi: 10.1111/1523-1747.ep12373073. [DOI] [PubMed] [Google Scholar]
  24. Schneider-Yin X., Schäfer B. W., Möhr P., Burg G., Minder E. I. Molecular defects in erythropoietic protoporphyria with terminal liver failure. Hum Genet. 1994 Jun;93(6):711–713. doi: 10.1007/BF00201578. [DOI] [PubMed] [Google Scholar]
  25. Schneider-Yin X., Schäfer B. W., Tönz O., Minder E. I. Human ferrochelatase: a novel mutation in patients with erythropoietic protoporphyria and an isoform caused by alternative splicing. Hum Genet. 1995 Apr;95(4):391–396. doi: 10.1007/BF00208962. [DOI] [PubMed] [Google Scholar]
  26. Schneider-Yin X., Taketani S., Schäfer B., Minder E. I. Recessive inheritance of erythropoietic protoporphyria with liver failure. Lancet. 1994 Jul 30;344(8918):337–337. [PubMed] [Google Scholar]
  27. Taketani S., Inazawa J., Nakahashi Y., Abe T., Tokunaga R. Structure of the human ferrochelatase gene. Exon/intron gene organization and location of the gene to chromosome 18. Eur J Biochem. 1992 Apr 1;205(1):217–222. doi: 10.1111/j.1432-1033.1992.tb16771.x. [DOI] [PubMed] [Google Scholar]
  28. Todd D. J., Hughes A. E., Ennis K. T., Ward A. J., Burrows D., Nevin N. C. Identification of a single base pair deletion (40 del G) in exon 1 of the ferrochelatase gene in patients with erythropoietic protoporphyria. Hum Mol Genet. 1993 Sep;2(9):1495–1496. doi: 10.1093/hmg/2.9.1495. [DOI] [PubMed] [Google Scholar]
  29. Tutois S., Montagutelli X., Da Silva V., Jouault H., Rouyer-Fessard P., Leroy-Viard K., Guénet J. L., Nordmann Y., Beuzard Y., Deybach J. C. Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease. J Clin Invest. 1991 Nov;88(5):1730–1736. doi: 10.1172/JCI115491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Wang X. Molecular characterization of a novel defect occurring de novo associated with erythropoietic protoporphyria. Biochim Biophys Acta. 1996 Aug 23;1316(3):149–152. doi: 10.1016/0925-4439(96)00003-8. [DOI] [PubMed] [Google Scholar]
  31. Wang X., Poh-Fitzpatrick M., Carriero D., Ostasiewicz L., Chen T., Taketani S., Piomelli S. A novel mutation in erythropoietic protoporphyria: an aberrant ferrochelatase mRNA caused by exon skipping during RNA splicing. Biochim Biophys Acta. 1993 Apr 30;1181(2):198–200. doi: 10.1016/0925-4439(93)90112-e. [DOI] [PubMed] [Google Scholar]
  32. Wang X., Poh-Fitzpatrick M., Chen T., Malavade K., Carriero D., Piomelli S. Systematic screening for RNA with skipped exons--splicing mutations of the ferrochelatase gene. Biochim Biophys Acta. 1995 Jun 9;1271(2-3):358–362. doi: 10.1016/0925-4439(95)00059-d. [DOI] [PubMed] [Google Scholar]
  33. Wang X., Poh-Fitzpatrick M., Piomelli S. A novel splicing mutation in the ferrochelatase gene responsible for erythropoietic protoporphyria. Biochim Biophys Acta. 1994 Oct 21;1227(1-2):25–27. doi: 10.1016/0925-4439(94)90101-5. [DOI] [PubMed] [Google Scholar]
  34. Whitcombe D. M., Carter N. P., Albertson D. G., Smith S. J., Rhodes D. A., Cox T. M. Assignment of the human ferrochelatase gene (FECH) and a locus for protoporphyria to chromosome 18q22. Genomics. 1991 Dec;11(4):1152–1154. doi: 10.1016/0888-7543(91)90044-f. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES